Use of Kif13A and AP-1 inhibitors for inhibiting melanogenesis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 11, 2014
Issued Date -
N/A
app pub date -
Aug 8, 2012
filing date -
Apr 22, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to novel pharmaceutical or cosmetic compositions comprising at least one inhibitor of a sub-unit of AP-1 adaptor complex, of a kinesin interacting with AP-1, in particular Kif13A, or of the interaction between a sub-unit of AP-1 adaptor complex and said kinesin, as well as the use of same to manufacture a drug intended for the treatment of pigmentary disorders and as a depigmentation agent.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully